You are receiving this message since your browser does not support Java Script or you have Java Scripts disabled. The following disclaimer is provided as an alternative to the information that would normally be seen on your monitor when you click on a link to a non-federal site.

"You are now leaving the NIDDK website. The NIDDK is not responsible for the content of web pages found on this linked website. Links to nonfederal organizations are provided solely as a service to our users. These links do not indicate an endorsement of these organizations by NIDDK or the federal government."


"*Nationwide studies refer to those offered in every US State."

Type 1 Diabetes Genetics Consortium  (T1DGC)

Who can participate?
The T1DGC has completed enrollment for the affected sibling pair families phase of the study. We would like to thank all of participants worldwide who helped the study reach this monumental goal.

We are continuing to recruit trios (father, mother, and a child with type 1 diabetes), as well as cases (with type 1 diabetes) and controls (no history of type 1 diabetes) from populations with a low prevalence of the disease only as we have adequate numbers of Caucasians of European origins. In Asia Pacific, this includes individuals from countries such as India and Thailand. In North America, this includes Mexican American and African American individuals.

What is this study?
The consortium is a group of diabetes researchers from around the world who have come together to collect samples and information from families with type 1 diabetes.
Why is it being done?
We are trying to discover how differences in the genes that we inherit from our parents contribute to the risk for development of type 1 diabetes. Genes are 'blue prints' in our bodies which we get from our parents at birth, that decide our characteristics like the color of our hair, our eyes and the shape of our bodies. Some genes are also involved in whether you have diabetes or not. If we find out more about these genes, we may be able to prevent diabetes in the future.
If I enroll in this study, what do I have to do?
If you want to help us, we will take some blood and ask you some questions about your diabetes and your health.
Can I participate in other studies if I participate in this one?
Yes
How can I learn more?
Visit the T1DGC website or contact the location nearest you.


Canada, Nationwide*


Alan Aldrich
Benaroya Research Institute at Virginia Mason
Phone: 800-888-4187
diabetes@benaroyaresearch.org


United Kingdom


Heather Withers
Addenbrooke’s Hospital
Cambridge, England
CB2 2QQ United Kingdom
Phone: +44-01223-763132
Fax: +44-01223-336996
hw258@cam.ac.uk


Australia, China, India, Malaysia, New Zealand, Philippines, Singapore, South Africa, Taiwan


Amanda Loth
Walter & Eliza Hall Institute of Medical Research
Royal Melbourne Hospital, Victoria 3050
Australia
Phone: +61-3-9345-2601
Phone: +61-3-9347-0852
Amanda.Loth@mh.org.au


Austria, Belgium, Bosnia/Herzeg, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Israel, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey


Ana Wagner
Steno Diabetes Center
Niels Steensensvej 2
DK-2820 Gentofte, Denmark
Phone: +45-4442-0380
Fax: +45-4443-7313
awgn@steno.dk


*Nationwide studies refer to those offered in every US State.
Last Updated: June 30, 2008

General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560 USA
For information about NIDDK programs: 301.496.3583